Citation: | BAI Yu, YANG Yaming. Application of azithromycin combined with simvastatin in treating patients with chronic obstructive pulmonary disease complicated with pulmonary hypertension[J]. Journal of Clinical Medicine in Practice, 2019, 23(10): 33-35. DOI: 10.7619/jcmp.201910010 |
[1] |
马肖龙. 阿奇霉素联合辛伐他汀治疗慢性阻塞性肺疾病合并肺动脉高压的临床疗效[J]. 中国临床药理学杂志, 2015, 31(4): 250-252. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ201504003.htm
|
[2] |
刘旭东, 吴俊丽, 刘云, 等. 辛伐他汀联合阿奇霉素治疗老年慢性阻塞性肺疾病合并肺动脉高压患者的疗效[J]. 实用医学杂志, 2016, 32(7): 1199-1200. doi: 10.3969/j.issn.1006-5725.2016.07.055
|
[3] |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞肺疾病诊治指南(2007修订版)[J]. 中华结核和呼吸杂志, 2007, 30(1): 8-17. doi: 10.3760/j:issn:1001-0939.2007.01.004
|
[4] |
马峰, 朱卫华. 小剂量大环内酯类药物联合辛伐他汀治疗慢性阻塞性肺疾病合并肺动脉高压疗效评价[J]. 医学综述, 2016, 22(1): 170-172. doi: 10.3969/j.issn.1006-2084.2016.01.049
|
[5] |
Chen W, Thomas J, Sadatsafavi M, et al. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis[J]. Lancet Respiratory Medicine, 2015, 3(8): 631-639. doi: 10.1016/S2213-2600(15)00241-6
|
[6] |
王艳, 史玉红, 李圣, 等. 阿奇霉素联合辛伐他汀对慢性阻塞性肺疾病合并肺动脉高压患者肺功能的影响[J]. 现代生物医学进展, 2017, 17(7): 138-140, 148. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX201707034.htm
|
[7] |
蒋衣果, 周梅芳, 朱建军, 等. 辛伐他汀联合法舒地尔治疗COPD合并肺动脉高压患者临床效果观察[J]. 西部医学, 2016, 28(5): 709-712. doi: 10.3969/j.issn.1672-3511.2016.05.031
|
[8] |
O′Donnell D E, Hernandez P, Kaplan A, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease-2008 update-highlights for primary care. [J]. Canadian Respiratory Journal Journal of the Canadian Thoracic Society, 2016, 15(4): 219-225. http://www.tandfonline.com/servlet/linkout?suffix=CIT0015&dbid=8&doi=10.1080%2F17476348.2018.1439741&key=18292855
|
[9] |
洪路贤, 王秋婷. 阿奇霉素片联合阿托伐他汀钙片治疗慢性阻塞性肺疾病合并肺动脉高压的临床研究[J]. 中国临床药理学杂志, 2018, 34(18): 8-10. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ201818002.htm
|
[10] |
姜妤, 郭小青, 陈曦, 等. 西地那非联合辛伐他汀治疗慢性阻塞性肺疾病合并肺动脉高压患者的效果分析[J]. 河北医药, 2017, 39(20): 3136-3138. doi: 10.3969/j.issn.1002-7386.2017.20.027
|
[11] |
刘勇进, 张意仲, 夏仁瑞, 等. 阿托伐他汀联合常规治疗方案对老年COPD合并肺动脉高压患者VEGF水平及肺功能的影响[J]. 实用药物与临床, 2016, 19(9): 1108-1110. https://www.cnki.com.cn/Article/CJFDTOTAL-LYLC201609013.htm
|
[12] |
酚妥拉明联合疏血通治疗COPD合并肺动脉高压的疗效及其对患者凝血状态及血清NO、NOS水平的影响[J]. 海南医学, 2018, 29(7): 919-923.
|
[13] |
覃燕文. 使用阿奇霉素和辛伐他汀对慢阻肺并发肺动脉高压患者进行治疗的效果分析[J]. 当代医药论丛, 2017, 15(9): 107-108. doi: 10.3969/j.issn.2095-7629.2017.09.080
|
[14] |
曾明旋, 程知音, 胡斌. 阿奇霉素联合他汀类药物在慢阻肺并发肺动脉高压中的应用效果[J]. 临床肺科杂志, 2016, 21(3): 471-473. doi: 10.3969/j.issn.1009-6663.2016.03.024
|
[15] |
王春芳. 阿奇霉素结合他汀类药物用于治疗慢阻肺并发肺动脉高压的疗效探讨[J]. 临床医药文献电子杂志, 2017, 4(29): 23-24. https://www.cnki.com.cn/Article/CJFDTOTAL-LCWX201729008.htm
|
[16] |
Detorres J P, Wilson D O, Sanchezsalcedo P, et al. Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score[J]. Am J Respir Crit Care Med, 2015, 191(3): 285-291. doi: 10.1164/rccm.201407-1210OC
|
[17] |
赵钰玲, 鱼军, 李建英. 阿奇霉素联合辛伐他汀治疗慢性阻塞性肺疾病合并肺动脉高压临床疗效的Meta分析[J]. 实用心脑肺血管病杂志, 2018, 26(3): 8-12. https://www.cnki.com.cn/Article/CJFDTOTAL-SYXL201803005.htm
|
[18] |
唐晨. 辛伐他汀治疗对慢性阻塞性肺疾病合并肺动脉高压患者心肺功能及炎性细胞因子的影响[J]. 现代中西医结合杂志, 2017, 26(8): 851-853. doi: 10.3969/j.issn.1008-8849.2017.08.018
|